Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.15666675
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.46 0.02 (1.39%)

90.93% Fall from 52W High

68,931

XNAS Volume

XNAS 26 Sep, 2025 11:24 AM (EDT)

Not Eligible

Expensive Valuation

15.7 / 100

Technically Bearish

30.6 / 100

1Yr Price target upside is 2652%

11 analysts

Pliant Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

90.93% Fall from 52W High

SWOT Analysis

Pliant Therapeutics Inc Live Price Chart